Get the Stockscreener App
0.8154
0.56%
-0.0046
After Hours:
.90
0.0846
+10.38%
Nektar Therapeutics Stock (NKTR) Forecast
The Nektar Therapeutics (NKTR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.4112, representing a +1,054% increase from the current price of $0.8154. The highest analyst price target is $9.8583, and the lowest is $8.9641.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NKTR Price Target
Average 6.0884
(+646.68% Upside)
Is Nektar Therapeutics (NKTR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.82 | Neutral |
| STOCH(9,6) | 39.52 | Neutral |
| STOCHRSI(14) | 35.71 | Neutral |
| MACD(12,26) | -0.0134 | Sell |
| ADX(14) | 13.61 | Neutral |
| William %R | -70.92 | Neutral |
| CCI(14) | 20.42 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8357
Sell
|
0.8343
Sell
|
| MA20 |
0.8736
Sell
|
0.8436
Sell
|
| MA50 |
0.8828
Sell
|
0.89
Sell
|
| MA100 |
1.0174
Sell
|
0.9756
Sell
|
| MA200 |
1.146
Sell
|
1.0108
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NKTR could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on NKTR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.82 indicates that NKTR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.52 indicates that NKTR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.71 indicates that NKTR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.61 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 20.42 indicates that NKTR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NKTR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nektar Therapeutics financial reports and earnings history, Nektar Therapeutics (NKTR) stock could reach $31.56 by 2030, $24.76 by 2040 and $70.48 by 2050. See the projected annual prices until 2050 of the Nektar Therapeutics stock below:
- Nektar Therapeutics (NKTR) is expected to reach an average price of $8.6362 in 2035, with a high prediction of $9.5027 and a low estimate of $8.6792. This indicates an $959.14% rise from the last recorded price of $0.8154.
- Nektar Therapeutics (NKTR) stock is projected to chart a bullish course in 2040, with an average price target of $23.85, representing an $2,825% surge from its current level. The forecast ranges from a conservative $23.87 to a sky-high $24.76.
- Our analysts predict Nektar Therapeutics (NKTR) to jump 5,221% by 2045, soaring from $43.86 to an average price of $43.39, potentially reaching $44.37. While $43.86 is the low estimate, the potential upside is significant.
- Nektar Therapeutics (NKTR) stock is expected to climb by 2050, reaching an average of $70.69, a $8,570% jump from its current level. However, a wide range of estimates exists, with high and low targets of $70.48 and $66.95, respectively, highlighting the market's uncertainty.
Nektar Therapeutics Stock (NKTR) Year by Year Forecast
Nektar Therapeutics Stock (NKTR) Price Forecast for 2025
Nektar Therapeutics Stock (NKTR) is expected to reach an average price of $6.0884 in 2025, with a high prediction of $9.8583 and a low estimate of $2.3185. This indicates an +646.68% rise from the last recorded price of $0.8154.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $9.9564 | $8.9641 | $9.8583 | +1,121% |
| May, 2025 | $7.0186 | $8.0186 | $9.3494 | +760.76% |
| June, 2025 | $4.6809 | $6.3499 | $7.8398 | +474.06% |
| July, 2025 | $3.3662 | $4.324 | $3.524 | +312.83% |
| August, 2025 | $1.7135 | $2.3185 | $2.6224 | +110.14% |
| September, 2025 | $3.4608 | $2.4746 | $2.3308 | +324.43% |
| October, 2025 | $5.8561 | $5.7588 | $5.423 | +618.19% |
| November, 2025 | $7.7584 | $5.5522 | $6.6484 | +851.48% |
| December, 2025 | $7.9737 | $7.1176 | $7.4914 | +877.89% |
Nektar Therapeutics Stock (NKTR) Price Forecast for 2026
The predicted value for Nektar Therapeutics (NKTR) in 2026 is set at an average of $3.2051. Estimates vary from a peak of $6.396 to a trough of $0.0142, indicating an +293.07% surge from the present price of $0.8154.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.596 | $6.7929 | $6.396 | +708.92% |
| February, 2026 | $4.2082 | $6.0593 | $6.319 | +416.09% |
| March, 2026 | $5.5505 | $4.6013 | $3.9344 | +580.71% |
| April, 2026 | $2.9242 | $0.0142 | $4.9435 | +258.62% |
| May, 2026 | $0.1019 | $0.0219 | $2.7181 | -87.50% |
| June, 2026 | $2.5103 | $1.4673 | $1.1589 | +207.87% |
| July, 2026 | $1.6257 | $1.2495 | $1.0334 | +99.37% |
| August, 2026 | $2.5679 | $2.9087 | $2.2479 | +214.93% |
| September, 2026 | $2.2733 | $2.7471 | $2.6541 | +178.79% |
| October, 2026 | $3.4455 | $3.4563 | $2.9455 | +322.56% |
| November, 2026 | $3.3078 | $3.8278 | $4.6817 | +305.67% |
| December, 2026 | $0.3231 | $0.3868 | $2.7209 | -60.37% |
Nektar Therapeutics Stock (NKTR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nektar Therapeutics (NKTR) is $5.331, with a high forecast of $10.28 and a low forecast of $0.3862. This indicates an +553.79% increase from the last price of $0.8154.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4604 | $0.3862 | $0.6507 | +79.10% |
| February, 2027 | $5.5977 | $2.7385 | $3.7377 | +586.49% |
| March, 2027 | $3.193 | $4.733 | $5.5648 | +291.59% |
| April, 2027 | $4.3353 | $3.1791 | $3.6753 | +431.67% |
| May, 2027 | $5.5475 | $5.4183 | $4.9914 | +580.34% |
| June, 2027 | $4.9729 | $5.2029 | $5.2998 | +509.87% |
| July, 2027 | $9.6551 | $5.4859 | $9.449 | +1,084% |
| August, 2027 | $10.06 | $9.3343 | $9.6974 | +1,133% |
| September, 2027 | $10.54 | $10.37 | $10.16 | +1,193% |
| October, 2027 | $10.18 | $10.45 | $10.28 | +1,149% |
| November, 2027 | $9.3972 | $9.5972 | $9.5242 | +1,052% |
| December, 2027 | $7.5526 | $8.1326 | $9.2303 | +826.24% |
Nektar Therapeutics Stock (NKTR) Price Forecast for 2028
In 2028, Nektar Therapeutics (NKTR) is projected to reach an average price of $7.4774, with a high projection of $8.4771 and a low estimate of $6.4776. This indicates an +817.02% rise from the last price of $0.8154.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.2548 | $8.0456 | $8.1948 | +912.37% |
| February, 2028 | $8.6371 | $8.5279 | $8.4771 | +959.25% |
| March, 2028 | $7.5424 | $7.6124 | $8.1852 | +825.00% |
| April, 2028 | $7.6347 | $7.5086 | $7.3797 | +836.31% |
| May, 2028 | $8.19 | $7.7639 | $7.64 | +904.42% |
| June, 2028 | $7.5923 | $7.6823 | $7.9631 | +831.11% |
| July, 2028 | $6.5546 | $6.6146 | $7.1804 | +703.85% |
| August, 2028 | $7.7599 | $6.4776 | $7.6938 | +851.67% |
| September, 2028 | $7.731 | $7.8571 | $7.8181 | +848.12% |
| October, 2028 | $7.2758 | $7.3744 | $7.3252 | +792.30% |
| November, 2028 | $6.9404 | $6.9686 | $7.1809 | +751.17% |
| December, 2028 | $6.5568 | $6.582 | $6.8289 | +704.12% |
Nektar Therapeutics Stock (NKTR) Price Forecast for 2029
The 2029 price forecast for Nektar Therapeutics Stock (NKTR) is $15.24 on average, with a high prediction of $30.24 and a low estimate of $0.2334. This represents an +1,769% increase from the previous price of $0.8154.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.0615 | $6.0615 | $6.4304 | +643.38% |
| February, 2029 | $5.5306 | $5.5447 | $5.9394 | +578.27% |
| March, 2029 | $5.0361 | $5.1758 | $5.3947 | +517.62% |
| April, 2029 | $4.7761 | $4.8241 | $4.9193 | +485.74% |
| May, 2029 | $4.3246 | $4.3491 | $4.6272 | +430.36% |
| June, 2029 | $3.8267 | $3.8817 | $4.1324 | +369.31% |
| July, 2029 | $3.359 | $3.419 | $3.7118 | +311.94% |
| August, 2029 | $2.847 | $2.8842 | $3.2136 | +249.16% |
| September, 2029 | $2.2792 | $2.3313 | $2.7024 | +179.52% |
| October, 2029 | $1.5134 | $1.5959 | $2.0747 | +85.60% |
| November, 2029 | $0.7592 | $0.7992 | $1.38 | -6.89% |
| December, 2029 | $31.36 | $0.2334 | $30.24 | +3,746% |
Nektar Therapeutics Stock (NKTR) Price Forecast for 2030
Nektar Therapeutics Stock (NKTR) is expected to reach an average price of $36.96 in 2030, with a high forecast of $44.64 and a low forecast of $29.29. This signifies an +4,433% surge from the last price of $0.8154.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $31.48 | $32.14 | $31.56 | +3,761% |
| February, 2030 | $30.46 | $29.29 | $28.92 | +3,635% |
| March, 2030 | $32.07 | $32.13 | $31.91 | +3,833% |
| April, 2030 | $44.82 | $45.24 | $44.32 | +5,397% |
| May, 2030 | $42.97 | $42.12 | $44.64 | +5,170% |
| June, 2030 | $43.79 | $44.04 | $42.79 | +5,271% |
| July, 2030 | $38.26 | $40.34 | $42.26 | +4,592% |
| August, 2030 | $37.26 | $37.94 | $37.96 | +4,470% |
| September, 2030 | $31.01 | $37.01 | $36.30 | +3,703% |
| October, 2030 | $33.52 | $34.56 | $36.11 | +4,011% |
| November, 2030 | $39.66 | $34.40 | $37.00 | +4,764% |
| December, 2030 | $38.08 | $37.97 | $37.52 | +4,570% |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):